Related Experiment Videos
Diagnosis of interstitial lung disease by a percutaneous lung biopsy sample
Archives of Disease in Childhood
|February 1, 1994
Insights
Percutaneous lung biopsy accurately diagnosed interstitial lung disease in young children. This procedure led to timely and appropriate treatment for pediatric patients with rare lung conditions.
Area of Science:
- Pediatric Pulmonology
- Diagnostic Pathology
Background:
- Interstitial lung disease (ILD) in young children is challenging to diagnose.
- Early diagnosis is crucial for effective management and treatment.
Purpose of the Study:
- To evaluate the utility of percutaneous lung biopsy in diagnosing interstitial lung disease in children under 42 months.
- To assess the safety and efficacy of the diagnostic procedure.
Main Methods:
- Percutaneous lung biopsy was performed on nine children under 42 months of age.
- Biopsy samples were analyzed to determine the underlying lung pathology.
Main Results:
- Eight children were diagnosed with fibrosing alveolitis.
- One child was diagnosed with Pneumocystis carinii pneumonia.
- The procedure was associated with minimal complications.
Conclusions:
- Percutaneous lung biopsy is a safe and effective method for diagnosing interstitial lung disease in infants and young children.
- Biopsy results facilitated appropriate and timely treatment for pediatric patients.
Abstract:
A percutaneous lung biopsy sample was used to diagnose interstitial lung disease in nine children aged less than 42 months. Fibrosing alveolitis was diagnosed in eight children and Pneumocystis carinii pneumonia in one child. Complications associated with the procedure were minimal and the results of the biopsy sample enabled each child to be treated appropriately.